Search Results - Arnaud Jacquel

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies by Guillaume Robert, Arnaud Jacquel, Patrick Auberger

    Published in Cells (2019-10-01)
    Get full text
    Article


  2. 2

    Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia by Patrick Auberger, Cécile Favreau, Coline Savy, Arnaud Jacquel, Guillaume Robert

    Published in Cellular & Molecular Biology Letters (2024-07-01)
    Get full text
    Article


  3. 3

    VEXAS, Chediak–Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator? by Coline Savy, Maxence Bourgoin, Thomas Cluzeau, Arnaud Jacquel, Guillaume Robert, Patrick Auberger

    Published in Cellular & Molecular Biology Letters (2025-01-01)
    Get full text
    Article


  4. 4

    The generation, activation, and polarization of monocyte-derived macrophages in human malignancies by Paul Chaintreuil, Paul Chaintreuil, Emeline Kerreneur, Emeline Kerreneur, Maxence Bourgoin, Maxence Bourgoin, Coline Savy, Coline Savy, Cécile Favreau, Cécile Favreau, Guillaume Robert, Guillaume Robert, Arnaud Jacquel, Arnaud Jacquel, Patrick Auberger, Patrick Auberger

    Published in Frontiers in Immunology (2023-04-01)
    Get full text
    Article


  5. 5

    Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy by Benoist Pruvot, Arnaud Jacquel, Nathalie Droin, Patrick Auberger, Didier Bouscary, Jérome Tamburini, Marc Muller, Michaela Fontenay, Johanna Chluba, Eric Solary

    Published in Haematologica (2011-04-01)
    Get full text
    Article


  6. 6

    PIM2 inhibition promotes MCL1 dependency in plasma cells involving integrated stress response-driven NOXA expression by Marion Haas, Sabrina Cherfa, Léa Nguyen, Maxence Bourgoin, Gersende Caron, Elise Dessauge, Tony Marchand, Laurent Delpy, Patrick Auberger, Jérôme Moreaux, Arnaud Jacquel, Thierry Fest

    Published in Nature Communications (2025-01-01)
    Get full text
    Article


  7. 7

    Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity by Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti

    Published in Molecular Cancer (2021-01-01)
    Get full text
    Article


  8. 8

    ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity by Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti

    Published in Molecular Cancer (2021-01-01)
    Get full text
    Article


  9. 9

    Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001 by Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, Olivia Rastoin, Rosie Dawaliby, Thomas Schmitt, Maxence Bourgoin, Héliciane Palenzuela, Anne-Laure Rossi, Damien Ambrosetti, Jerome Durivault, Frederic Luciano, Delphine Borchiellini, Julie Le Du, Leticia Christina Pires Gonçalves, Patrick Auberger, Rachid Benhida, Lisa Kinget, Benoit Beuselinck, Cyril Ronco, Gilles Pagès, Maeva Dufies

    Get full text
    Article


Search Tools: